Faith L. Charles - 16 Apr 2025 Form 4 Insider Report for CONDUIT PHARMACEUTICALS INC. (CDT)

Reporting relationship: Director
Issuer ticker: CDT
Reported as of: 16 Apr 2025
Net transaction value: +$100,000
SEC form: 4
Accepted by SEC: 17 Apr 2025, 16:05:08 UTC
Prior SEC filing: 01 Apr 2025
Next SEC filing: 10 Jul 2025
Source filing: View source filing
Reporting owner signature: /s/ Faith L. Charles

Key filing fact

Faith L. Charles filed Form 4 for CONDUIT PHARMACEUTICALS INC. (CDT) on 17 Apr 2025.

Key facts

This page summarizes Faith L. Charles's Form 4 filing for CONDUIT PHARMACEUTICALS INC. (CDT).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 17 Apr 2025, 16:05.

Change

Previous filing in this sequence was filed on 01 Apr 2025.
Current net transaction value: +$100,000.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CDT transaction

Common Stock

Award

Transaction value: $100,000
Shares: +115,194
Change %: +230%
Price: $0.8681
Shares after: 165,238
Date: 16 Apr 2025
Ownership: Direct

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Faith L. Charles is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

SEC remarks

Effective as of April 16, 2025, Faith Charles (the "Reporting Person") resigned from her position as a member of the Board of Directors of Conduit Pharmaceuticals Inc (the "Issuer"). As a result, the Reporting Person is no longer subject to Section 16 in connection with her transactions in equity securities of the Issuer and therefore will no longer report any such transactions on Form 4 or Form 5.